Abstract
Pediatric myelodysplastic syndrome (MDS), though rare, constitutes a distinct entity quite different from adult MDS. They have unique clinical features, aggressive clinical course with an overall mean survival of only 9.9 months. A pediatric approach to the WHO classification has become necessary since the WHO classification of MDS has failed to address the uniqueness of pediatric MDS. A new prognostic system also needs to be evolved since the international prognostic system has limited prognostic impact in children. Intensive chemotherapy such as the one used in de novo-acute myeloid leukemia (AML) leads to complete remission in some children and this may be the treatment of choice in pediatric MDS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harris NL, Jaffe Es, Diebold et al. World Health Organization classification of neoplastic diseases of the hematopoietic and meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
Cruetzig U, Cantu-Rajnoldi A, Ritter J et al. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany. Am J Pediatr Hematol Oncol 1987; 9: 324–330.
Brandwein JM, Horsman DE, Eaves AC et al. Childhood myelodysplasia; Suggested classification as myelodysplastic syndromes based on laboratory and clinical findings. Am J Pediatr Hematol Oncol 1990; 12: 63–70.
Van Wering ER, Kamps WA, Vossen JM et al. Myelodysplastic syndromes in childhood: Three case reports. Br J Haematol 1985; 60: 137–142.
Tuncer MA, Pagliuca A, Heiesonmez G, Yetgin S, Ozsoylu S, Mufti GJ. Primary myelodysplastic syndrome in childhood. The clinical experience in 33 patients. Br J Hematol 1992; 82: 347–353.
Castro-Malaspina H, Schaison G, Passe S et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations and identification of prognostic factors. Cancer 1984; 54: 675–680.
Jain Pawan, Kapoor Gauri. Myelodysplastic syndrome in children. In Lokeshwar MR, Shah NK, Agarwal Bharat, Sachdeva Anupam, eds. IAP speciality series on pediatric hematology and oncology, Mumbai. Indian Academy of Pediatrics 2006; 332–340.
Hasle H, Niemeyer CM, Chessells JM et al. A pediatric approach to the WHO Classification of Myelodysplastic and Myeloproliferative disease. Leukemia 2003; 17: 277–282.
Brunning RD, Bennett JM, Flandrin G et al. Myelodysplastic syndrome. In Jaffe ES, Harris NL, Stein H et al. eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press 2001; 63–73.
Lasky J, Sakamoto KM. Myelodysplastic and myeloproliferative disorders of childhood. Med Gen Med 2005; 7: 21–30.
Tuncer MA, Pagliuca A, Hicsonmez G et al. Primary myelodysplastic syndrome in children:the clinical experience in 33 cases. British Journal of Haematology 1992; 82: 347–353.
Passmore SJ, Hann IM. Pediatric myelodysplasia. Br Med Bull 1996; 52: 778–786.
Virchis A, Koh M, Rankin P et al. Fludarabine cytosine arabinoside granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukemia or myelodysplastic syndromes. Br J Haematol 2004; 124: 26–32.
Locatelli F, Niemeyer C, Angelucci E et al. Allogenenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood:a report from the European Working Group on Myelodysplastic syndrome in Childhood. J Clin Oncol 1997; 15: 566–573.
Woods WG, Neudorf S, Gold S et al. Children’s Cancer Group. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: a report from the Children’s Cancer Group. Blood 2001; 97: 56–62.
Sasaki H, Manabe A, Kojima S et al. Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan. Leukemia 2001; 15: 1713–1720.
Hasle H, Baumann I, Bergstraser E et al. International prognostic scoring system (IPSS) for childhood MDS and JMML. Blood 2001; 98: 624a.
Passmore SJ, Ham IM, Stiller Ca et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85: 1742–1750.
Mandel K, Dror Y, Poon A et al. A practical comprehensive classification for pediatric myelodysplastic syndromes: the CCC system. J Pediatr Hematol Oncol 2002; 24: 343–353.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tilak, V., Sookmane, D.D., Gupta, V. et al. Myelodysplastic Syndrome. Indian J Pediatr 75, 729–732 (2008). https://doi.org/10.1007/s12098-008-0138-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-008-0138-y